Lamivudine And Zidovudine Tablets IP

Name: Lamivudine And Zidovudine Tablets IP
Brand: NEETCO BIOPHARMA
Price: 499 INR
Availability: InStock

Price 499 INR/ Piece

Get a Price/Quote

MOQ : 1 Piece

Lamivudine And Zidovudine Tablets IP Specification

Dosage Form
Tablet

Appearance
White to off-white, film-coated tablets

Medicine Type
Allopathic

Molecular Formula
Lamivudine: C8H11N3O3S, Zidovudine: C10H13N5O4

CAS No
61177-45-5 (Lamivudine), 30516-87-1 (Zidovudine)

Dosage
150 mg Lamivudine + 300 mg Zidovudine

Pacakaging (Quantity Per Box)
60, 100 tablets per box

Grade
Pharmaceutical Grade

Expiration Date
36 months from the date of manufacture

Salt Composition
Lamivudine and Zidovudine

Assay
Lamivudine: 98 - 102%, Zidovudine: 98 - 102%

Indication
Indicated in combination with other antiretroviral agents for the treatment of HIV infection

Origin of Medicine
India

Usage
For the treatment of HIV-1 infection

Storage
Store below 30C, protect from light and moisture

Patient Population
Adults and adolescents

Prescription Status
Prescription Only Medicine (POM)

Adverse Effects
Headache, nausea, fatigue, anaemia, neutropenia

Therapeutic Class
Antiretroviral (NRTI Combination)

Regulatory Approval
WHO-GMP, ISO certified manufacturing

Container Type
HDPE Bottle or Blister pack

Administration Route
Oral

Strength
150 mg/300 mg

Contraindications
Known hypersensitivity to Lamivudine, Zidovudine or any other ingredient in the formulation

Drug Interactions
May interact with other antiretroviral drugs; consult physician

Shelf Life
Up to 3 years

About Lamivudine And Zidovudine Tablets IP

Lamivudine and Zidovudine Tablets IP is a popular combination antiretroviral medication designed for exceptional efficacy in managing HIV-1 infection. Powered by pharmaceutical grade Lamivudine (150 mg) and Zidovudine (300 mg), these splendid white to off-white, film-coated tablets are conveniently administered orally. Each batch is manufactured in India at stellar WHO-GMP, ISO certified plants and securely packaged in HDPE bottles or blister packs. With a stellar shelf life of up to three years, it ensures consistent, reliable therapy. Consult your physician due to possible drug interactions and contraindications. Reserve your supply now and experience marked improvements in patient outcomes!

Advantage, Plant Application, and Used By

Lamivudine and Zidovudine Tablets IP deliver a stellar advantage by combining two NRTIs, enhancing HIV-1 treatment effectiveness and reducing resistance risk. Manufactured in ISO and WHO-GMP certified plants, this exceptional therapy suits global healthcare applications. Widely used by adults and adolescents under prescription, it is trusted by healthcare professionals worldwide for its splendid efficacy and safety standards.

Sample Availability, Supply Ability, and Dispatch

Lamivudine and Zidovudine Tablets IP samples are available for genuine inquiries, allowing evaluation before placing bulk orders. Our supply ability is robust, ensuring prompt and consistent dispatching even for larger orders. Sale price is offered at a competitive markdown, factoring in quantity. FOB Port options are flexible, supporting seamless export and global distribution. A nominal charge may apply for sample provision.

FAQ's of Lamivudine And Zidovudine Tablets IP:

Q: How should Lamivudine and Zidovudine Tablets IP be taken for optimal results?

A: The tablets are administered orally, typically as prescribed by your healthcare provider, and are best taken at the same times each day to maintain consistent drug levels.

Q: What are the primary benefits of using this NRTI combination therapy?

A: This therapy offers exceptional viral suppression, reduces HIV resistance development, and is trusted for its splendid safety profile and efficacy in adults and adolescents.

Q: When is this medicine contraindicated for HIV patients?

A: Lamivudine and Zidovudine Tablets IP should not be used in individuals with known hypersensitivity to either ingredient or any other component of the formulation.

Q: Where is this medicine manufactured and what are its regulatory approvals?

A: The medicine is manufactured in India at WHO-GMP and ISO certified facilities, assuring international quality and regulatory compliance.

Q: What adverse effects might occur during usage?

A: Possible adverse effects include headache, nausea, fatigue, anaemia, and neutropenia. It's important to consult your healthcare provider if any side effects appear.

Tell us about your requirement